Navigation Links
SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
Date:5/1/2012

BELLEVUE, Wash., May 1, 2012 /PRNewswire/ -- SCOLR Pharma, Inc. (OTCQB: SCLR) announced today that effective May 1, 2012 Clem Calabrese will be joining the SCOLR team as Director of Field Sales to lead our aggressive field sales & marketing activities.  Clem brings a wealth of field sales experience to SCOLR and will be primarily responsible for working with our existing sales staff, the Emerson Group and our retail customers in order to ensure we aggressively grow our sales while providing the utmost in customer service.

Clem brings over 35 years of Branded and Store Brand Sales & Marketing experience with Major Consumer Products Companies.

Stephen Turner, President and CEO of SCOLR, said: "We are excited to have Clem join the SCOLR team.  He is an impressive individual and will most assuredly provide us with additional sales opportunities as we continue to grow our consumer products sales.  The depth of his relationships and contacts within the industry will enable SCOLR to continue the momentum created with our CDT® Controlled Release Technology with retailers."

About SCOLR Pharma:

Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT® platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Its CDT® drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http://www.scolr.com/.

Forward looking statements:                           &
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SCOLR Pharma, Inc. Provides Product Information on Website
2. SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
3. SCOLR Pharmas Partner to Commence Bioequivalence Study of Ondansetron
4. SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products
5. SCOLR Pharma, Inc. Announces Second Quarter 2011 Financial Results
6. SCOLR Pharma, Inc. First Quarter 2011 Financial Results
7. SCOLR Pharma, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
8. SCOLR Pharma, Inc. Reports 2010 Financial Results, Provides Updates on Advances in Nutritionals, OTC Drugs
9. SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application
10. SCOLR Pharma, Inc. Retains Nicholas Hall & Company
11. SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal, and metabolic diseases, today ... evaluating tenapanor in Stage 3 chronic kidney disease ... did not meet the primary endpoint of decreasing ... to patients receiving placebo. Ardelyx ...
(Date:5/5/2015)... WORTH, Texas , May 5, 2015 ... was valued at $94.9 million in 2014, and is ... a CAGR of 7.8% from 2014 to 2019. ... Glaucoma Surgery Device Market for an analysis of industry ... and figures. http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html ...
(Date:5/5/2015)...  Desert Valley Medical Center, named a Top 100 Hospitals® ... U.S. hospital to deploy the wireless Leaf Patient Monitoring System ... duration of labor and risk of caesarian births. ... caesarean birth is reduced in mothers who are upright and ... are given epidurals and tend to lie in their labor ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
... , LINCOLNSHIRE, Ill. , Jan. ... of health care products in the emergency medical services (EMS) ... Inc.  Headquartered in Arlington, Texas , CVC is a ... medical services markets.   , The privately negotiated transaction further ...
... , ST. LOUIS , Jan. 12 ... the Celsius® RMT ThermoCool® catheter has been approved by ... Stereotaxis, magnetic navigation system for the treatment of Type ... ablation catheter resulting from the on-going co-development agreement between ...
Cached Medicine Technology:Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 2Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products 3Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 2Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter 3
(Date:5/6/2015)... (PRWEB) May 06, 2015 Launch Corporation, LLC. ... opened its new Nashua location at 17 Tanguay Avenue. Owned ... be the duo’s second Launch location in New England. , ... new team,” said Rob Arnold, founder, co-owner and CEO of ... and we look forward to seeing them continue to establish ...
(Date:5/6/2015)... 2015 The SGNY Group LLC (SGNY), ... announced today that it was named a Platinum winner ... video produced on behalf of Intarcia Therapeutics. SGNY ... motion graphics. , The competition sponsored by the Association ... entries from 22 countries. The competition is an ...
(Date:5/5/2015)... LINCOLN, Neb. (PRWEB) May 06, 2015 It’s ... are invited to bring their classic cars and motorcycles to ... 12 from 5 to 8 p.m. at the Lincoln VA ... fun way for Veterans to check out each other’s rides, ... Veterans Affairs about benefits and services. , Staff from ...
(Date:5/5/2015)... Ras Al Khaimah, UAE (PRWEB) May 05, 2015 ... Grace Century , FZ LLC has announced that ... ’, monthly enrollment for Store-A-Tooth™ increased once again--in April, ... the company’s 40th month of increased record volume and ... , Marketing for Provia’s dental stem cell biobank is ...
(Date:5/5/2015)... 05, 2015 “Given that Hispanics are one ... the CDC report are a major step in the arsenal ... everyone. For the past 30 years, data have accumulated that ... Today we see the urgency and the need to create ... health outcomes for all,” said Jane L. Delgado, PhD, MS, ...
Breaking Medicine News(10 mins):Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2
... in Celebrity Foursome, WASHINGTON, May 6 Lung ... John,Atkinson has won the Golf Digest U.S. Open Contest. ... entries., He will try to break 100 at ... this year,s U.S. Open. Atkinson will compete in a ...
... This month something exciting,is happening in Nashville. Experts ... gathering at the Gaylord Opryland Resort and,Convention Center ... Patient Safety Congress. NPSF has been hosting this ... full spectrum of stakeholders,together in order to share ...
... N.J., May 6 Medical Product Outsourcing,magazine, ... the latest installment of its successful symposium,series., ... year,s East Coast event, the upcoming,Medical Product ... to San Mateo, Calif., on May 21, ...
... 51.9 Million Unique Monthly Users and 1.2 ... Billion Quarterly Page Views, ... financial results for the three months ended March,31, 2008., "Our ... its position as the leading source of health,information for both consumers ...
... dysfunction while awaiting operation rarely turns chronic ... patients who have short-term kidney dysfunction while awaiting ... they have their transplant, says a U.S. study. ... dysfunction while awaiting liver transplantation, which has led ...
... is widespread among U.S. adolescents and young adults ages 14 ... the University at Buffalos Research Institute on Addictions (RIA). ... the first national survey of its kind show problem gambling ... (for example, gambling more than you intended or stealing money ...
Cached Medicine News:Health News:Lung Cancer Alliance Advocate Wins Golf Digest Contest 2Health News:Annual NPSF Patient Safety Congress 2Health News:Annual NPSF Patient Safety Congress 3Health News:Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies 2Health News:Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies 3Health News:WebMD Announces First Quarter Financial Results 2Health News:WebMD Announces First Quarter Financial Results 3Health News:WebMD Announces First Quarter Financial Results 4Health News:WebMD Announces First Quarter Financial Results 5Health News:WebMD Announces First Quarter Financial Results 6Health News:WebMD Announces First Quarter Financial Results 7Health News:WebMD Announces First Quarter Financial Results 8Health News:WebMD Announces First Quarter Financial Results 9Health News:WebMD Announces First Quarter Financial Results 10Health News:WebMD Announces First Quarter Financial Results 11Health News:WebMD Announces First Quarter Financial Results 12Health News:WebMD Announces First Quarter Financial Results 13Health News:WebMD Announces First Quarter Financial Results 14Health News:WebMD Announces First Quarter Financial Results 15Health News:WebMD Announces First Quarter Financial Results 16Health News:WebMD Announces First Quarter Financial Results 17Health News:WebMD Announces First Quarter Financial Results 18Health News:WebMD Announces First Quarter Financial Results 19Health News:WebMD Announces First Quarter Financial Results 20Health News:Kidney Trouble Short-Lived in Most Liver Transplant Patients 2Health News:Estimated 750,000 problem gamblers among America's youth 2Health News:Estimated 750,000 problem gamblers among America's youth 3
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: